Steward Partners Investment Advisory’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.8K | Hold |
2,000
| – | – | ﹤0.01% | 3103 |
|
|
2025
Q1 | $7.08K | Hold |
2,000
| – | – | ﹤0.01% | 3255 |
|
|
2024
Q4 | $7.56K | Hold |
2,000
| – | – | ﹤0.01% | 3215 |
|
|
2024
Q3 | $6.48K | Hold |
2,000
| – | – | ﹤0.01% | 3109 |
|
|
2024
Q2 | $3.8K | Hold |
2,000
| – | – | ﹤0.01% | 3128 |
|
|
2024
Q1 | $5.68K | Hold |
2,000
| – | – | ﹤0.01% | 3001 |
|
|
2023
Q4 | $29.4K | Sell |
2,000
-200
| -9% | -$2.94K | ﹤0.01% | 2210 |
|
|
2023
Q3 | $40.3K | Buy |
2,200
+1,100
| +100% | +$20.1K | ﹤0.01% | 2006 |
|
|
2023
Q2 | $23.7K | Buy |
1,100
+100
| +10% | +$2.16K | ﹤0.01% | 2205 |
|
|
2023
Q1 | $29.3K | Sell |
1,000
-100
| -9% | -$2.93K | ﹤0.01% | 2087 |
|
|
2022
Q4 | $40.6K | Buy |
1,100
+50
| +5% | +$1.85K | ﹤0.01% | 1926 |
|
|
2022
Q3 | $30K | Sell |
1,050
-50
| -5% | -$1.43K | ﹤0.01% | 2016 |
|
|
2022
Q2 | $21K | Hold |
1,100
| – | – | ﹤0.01% | 2194 |
|
|
2022
Q1 | $14K | Buy |
+1,100
| New | +$14K | ﹤0.01% | 2513 |
|